Zahir Amoura

Research interests

Publications

• The 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria

  Arthritis & Rheumatology · 2023 · https://doi.org/10.1002/art.42624

• COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

  The Lancet Rheumatology · 2021 · https://doi.org/10.1016/s2665-9913(21)00059-x

• A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications

  Comptes Rendus Biologies · 2020 · 10.5802/crbiol.8

• Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2001180

• IgA dominates the early neutralizing antibody response to SARS-CoV-2

  Science Translational Medicine · 2020 · https://doi.org/10.1126/scitranslmed.abd2223

• Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

  Annals of the Rheumatic Diseases · 2020 · https://doi.org/10.1136/annrheumdis-2020-217960

• Microbial ecology perturbation in human IgA deficiency

  Science Translational Medicine · 2018 · https://doi.org/10.1126/scitranslmed.aan1217

• Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

  The Lancet Infectious Diseases · 2017 · https://doi.org/10.1016/s1473-3099(16)30521-7

• Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

  Cancer Discovery · 2015 · https://doi.org/10.1158/2159-8290.cd-15-0913

• Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated Erdheim-Chester Disease

  Journal of Clinical Oncology · 2014 · 10.1200/jco.2014.57.1950

• Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

  Blood · 2012 · https://doi.org/10.1182/blood-2012-07-446286

• High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

  Blood · 2012 · https://doi.org/10.1182/blood-2012-05-430140

• Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity

  Autoimmunity Reviews · 2012 · 10.1016/j.autrev.2012.06.006

• Spectrum of Cardiac Lesions in Behçet Disease

  Medicine · 2011 · https://doi.org/10.1097/md.0b013e3182428f49

• Human FoxP3+ regulatory T cells in systemic autoimmune diseases

  Autoimmunity Reviews · 2011 · 10.1016/j.autrev.2011.05.004

• Pathogenesis of Takayasu's arteritis: A 2011 update

  Autoimmunity Reviews · 2011 · 10.1016/j.autrev.2011.08.001

• CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients

  Blood · 2011 · https://doi.org/10.1182/blood-2010-06-294108

• Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

  Arthritis & Rheumatism · 2010 · https://doi.org/10.1002/art.27541

• Mortality in Behçet's disease

  Arthritis & Rheumatism · 2010 · https://doi.org/10.1002/art.27568

• Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor

  Immunity · 2009 · https://doi.org/10.1016/j.immuni.2009.03.019

• The immune paradox of sarcoidosis and regulatory T cells

  The Journal of Experimental Medicine · 2006 · https://doi.org/10.1084/jem.20050648

• Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus

  Arthritis & Rheumatism · 2006 · https://doi.org/10.1002/art.22156

• Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus

  The Journal of Immunology · 2005 · https://doi.org/10.4049/jimmunol.175.12.8392

• Cardiovascular Involvement, an Overlooked Feature of Erdheim-Chester Disease

  Medicine · 2004 · https://doi.org/10.1097/01.md.0000145368.17934.91

• Late-Onset Systemic Lupus Erythematosus

  Medicine · 2004 · 10.1097/01.md.0000147737.57861.7c

• Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus

  The American Journal of Medicine · 1992 · 10.1016/0002-9343(92)90049-h

Current projects

No projects listed.